“It’s a gift — and what do you do with gifts? You give them,” says prostate cancer survivor Jay Ciccotti. Ciccotti continues to share his gift of singing throughout the community thanks to radiation treatment at the Institute for Cancer. Here is his story.
Jay Ciccotti didn’t have any signs of prostate cancer. But in February 2016, when his yearly prostate screening (PSA) was an 11 — indicating that he had pretty advanced cancer — his treatment team sprung into action.
“Part of Ciccotti’s treatment included low dose rate (LDR) brachytherapy, a type of internal radiation therapy commonly prescribed to prostate cancer patients,” says Abhinand Peddada, MD, radiation oncologist at Renown Institute for Cancer.
LDR brachytherapy uses tiny radioactive “seeds” that are permanently implanted into the tumor. These seeds release low levels of radiation directly into the tumor over several weeks. Once treatment is over, the seeds are left in the body.
Convenience is a major advantage of LDR brachytherapy. For Ciccotti, he received five treatments and was back to his love for singing and playing golf in no time. Best of all: After the treatment, his PSA level has remained at a zero.
Ciccotti was so grateful for the love, support and comfort he received by the staff of Renown’s Institute for Cancer Radiation Therapy that he returned to the cancer center with members of his quartet to sing.
As all the staff gathered for the surprise serenade, Coccitti said, “When I was in here for treatment, I could feel the care and the concern that you all had for me and it made everything so much easier to go through, so thank you from my heart.”
You can listen to him perform around Reno with the Silver Dollar Chorus and a barbershop quartet.